Tags

Type your tag names separated by a space and hit enter

[The use of the 308 nm excimer laser for the treatment of psoriasis].

Abstract

BACKGROUND AND OBJECTIVE

Standard phototherapy for psoriasis (311 nm UVB or photochemotherapy) exposes the non-affected skin to potentially damaging irradiation. The use of 308 nm XeCl excimer laser allows the selective irradiation of psoriatic lesions. We evaluated its therapeutic effectiveness.

PATIENTS/METHODS

28 patients with plaque stage psoriasis were involved in the study, 26 of them could be evaluated. In each patient a single plaque was chosen and then exposed to the laser irradiation thrice weekly. The initial dose was twice the MED (minimal erythema dose); the dosage was increased by one MED every second treatment. The usual dosages were 2-5 MED, while the cumulative UVB dosage was 3.6-15.2 J/cm2. 17 Patients were treated 6 times, while 11 were treated 10 times. The Psoriasis Severity Index (PSI) was calculated for the individual plaque in order to assess the effectiveness of the therapy. The patients were followed regularly for 3 months following treatment, and then checked again at 1 year.

RESULTS

Most patients showed clear improvement. In 90% the PSI at the end of treatment was reduced by at least 50%; in 72% it was only 33% of the pre-treatment value. The results between the patients receiving 6 and 10 treatments were similar. In 6 patients, the psoriatic lesion was still absent after 1 year, while in an additional 7, there had been long term improvement. The most common side effects were erythema and pruritus (100%), blisters (35%) and post-inflammatory hyperpigmentation (80%).

CONCLUSION

The use of the 308 nm excimer laser is effective for chronic localized psoriasis and may lead to long-lasting remissions.

Authors+Show Affiliations

,

Hautklinik, Medizinische Fakultät der Karlsuniversität und Universitätskrankenhaus, Pilsen. fikrle@fnplzen.cz

Source

MeSH

Adolescent
Adult
Aged
Female
Follow-Up Studies
Humans
Lasers, Excimer
Male
Middle Aged
Psoriasis
Radiotherapy Dosage
Retreatment
Ultraviolet Therapy
Young Adult

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

16295041

Citation

Fikrle, Tomás, and Karel Pizinger. "[The Use of the 308 Nm Excimer Laser for the Treatment of Psoriasis]." Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 1, no. 7, 2003, pp. 559-63.
Fikrle T, Pizinger K. [The use of the 308 nm excimer laser for the treatment of psoriasis]. J Dtsch Dermatol Ges. 2003;1(7):559-63.
Fikrle, T., & Pizinger, K. (2003). [The use of the 308 nm excimer laser for the treatment of psoriasis]. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 1(7), pp. 559-63.
Fikrle T, Pizinger K. [The Use of the 308 Nm Excimer Laser for the Treatment of Psoriasis]. J Dtsch Dermatol Ges. 2003;1(7):559-63. PubMed PMID: 16295041.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The use of the 308 nm excimer laser for the treatment of psoriasis]. AU - Fikrle,Tomás, AU - Pizinger,Karel, PY - 2005/11/22/pubmed PY - 2015/10/28/medline PY - 2005/11/22/entrez SP - 559 EP - 63 JF - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG JO - J Dtsch Dermatol Ges VL - 1 IS - 7 N2 - BACKGROUND AND OBJECTIVE: Standard phototherapy for psoriasis (311 nm UVB or photochemotherapy) exposes the non-affected skin to potentially damaging irradiation. The use of 308 nm XeCl excimer laser allows the selective irradiation of psoriatic lesions. We evaluated its therapeutic effectiveness. PATIENTS/METHODS: 28 patients with plaque stage psoriasis were involved in the study, 26 of them could be evaluated. In each patient a single plaque was chosen and then exposed to the laser irradiation thrice weekly. The initial dose was twice the MED (minimal erythema dose); the dosage was increased by one MED every second treatment. The usual dosages were 2-5 MED, while the cumulative UVB dosage was 3.6-15.2 J/cm2. 17 Patients were treated 6 times, while 11 were treated 10 times. The Psoriasis Severity Index (PSI) was calculated for the individual plaque in order to assess the effectiveness of the therapy. The patients were followed regularly for 3 months following treatment, and then checked again at 1 year. RESULTS: Most patients showed clear improvement. In 90% the PSI at the end of treatment was reduced by at least 50%; in 72% it was only 33% of the pre-treatment value. The results between the patients receiving 6 and 10 treatments were similar. In 6 patients, the psoriatic lesion was still absent after 1 year, while in an additional 7, there had been long term improvement. The most common side effects were erythema and pruritus (100%), blisters (35%) and post-inflammatory hyperpigmentation (80%). CONCLUSION: The use of the 308 nm excimer laser is effective for chronic localized psoriasis and may lead to long-lasting remissions. SN - 1610-0379 UR - https://www.unboundmedicine.com/medline/citation/16295041/[The_use_of_the_308_nm_excimer_laser_for_the_treatment_of_psoriasis]_ L2 - http://www.diseaseinfosearch.org/result/6059 DB - PRIME DP - Unbound Medicine ER -